All clinical conditions

Clinical condition

Complex PTSD (C-PTSD)

ICD-11 6B41 (distinct from DSM-5-TR PTSD)

ICD-11 recognized clinical entity distinct from DSM-5-TR PTSD. Cumulative or relational trauma producing classical PTSD symptoms plus disturbances in self-organization. Treatment is stage-based with longer trajectory than acute PTSD.

Common ways people search for this

Complex PTSD treatmentCPTSD vs PTSDChildhood trauma adult symptomsDevelopmental traumaKetamine complex PTSD
The short version
  • Complex PTSD (C-PTSD) is an ICD-11-recognized clinical entity (code 6B41) distinct from DSM-5-TR PTSD. DSM-5-TR does not have a separate C-PTSD diagnosis; it folds these presentations under PTSD with dissociative subtype or related specifiers.
  • ICD-11 C-PTSD requires the three classical PTSD symptom clusters (re-experiencing, avoidance, persistent sense of current threat) PLUS three "disturbances in self-organization" clusters: affective dysregulation, negative self-concept, and disturbances in relationships.
  • Typically arises from prolonged, repeated, or relational trauma — childhood abuse, captivity, ongoing domestic violence, prolonged combat exposure — where escape was difficult or impossible.
  • Treatment is STAGE-BASED: phase 1 stabilization and safety (skills building, affect regulation), phase 2 trauma processing (when safety established), phase 3 reintegration and meaning-making. Cloitre and colleagues' phase-based model is the most-cited framework.
  • Trauma-focused therapies (Cognitive Processing Therapy, Prolonged Exposure, EMDR, narrative therapy) effective for PTSD often need adaptation in C-PTSD — slower pacing, more attention to safety, more co-regulation work before processing trauma material.
  • Ketamine's evidence in C-PTSD specifically is preliminary. The 2025 Beaglehole/Glue PTSD ketamine RCT showed measurable benefit in treatment-resistant PTSD; extension to C-PTSD is plausible but not yet trial-tested specifically.

Clinical definition

ICD-11 defines complex post-traumatic stress disorder (6B41) as a disorder that develops following exposure to an event or series of events of an extremely threatening or horrific nature, most commonly prolonged or repetitive events from which escape is difficult or impossible. The diagnosis requires all three classical PTSD criteria: (1) re-experiencing the traumatic event(s) in the present, (2) deliberate avoidance of reminders, (3) persistent perceptions of heightened current threat. C-PTSD additionally requires three "disturbances in self-organization" (DSO) criteria: (1) severe and pervasive problems in affect regulation (affective dysregulation), (2) persistent beliefs about oneself as diminished, defeated, or worthless (negative self-concept), and (3) persistent difficulties in sustaining relationships and feeling close to others (disturbances in relationships). DSM-5-TR did NOT adopt C-PTSD as a separate diagnosis; instead, DSM-5-TR PTSD includes a "with dissociative symptoms" specifier and broader negative-cognition criteria that capture some but not all of the ICD-11 C-PTSD construct. The clinical distinction matters because phase-based treatment is more often warranted in C-PTSD than in single-incident PTSD, and the timeline of recovery is typically longer.

How it differs from related conditions

vs. DSM-5-TR PTSD

DSM-5-TR PTSD has four symptom clusters (intrusion, avoidance, negative alterations in cognition and mood, alterations in arousal and reactivity). ICD-11 PTSD has three (re-experiencing, avoidance, current threat). C-PTSD adds the three DSO clusters on top of ICD-11 PTSD. A patient may meet DSM-5-TR PTSD and ICD-11 C-PTSD simultaneously; the diagnostic systems frame the same patient differently.

vs. Borderline personality disorder (BPD)

Significant overlap in affect dysregulation, negative self-concept, and relationship difficulties. Distinguishing features: BPD includes identity disturbance, suicidality, and characteristic interpersonal patterns (idealization/devaluation) not required for C-PTSD; C-PTSD requires a documented trauma history that BPD does not. Many patients meet both. Phase-based trauma treatment can apply to either, but treatment emphases differ.

vs. Dissociative disorders (DID, DD-NOS)

Dissociative identity disorder and other dissociative disorders involve identity fragmentation, dissociative amnesia, or marked dissociative phenomenology. These may co-occur with C-PTSD or PTSD. Dissociative features in C-PTSD do not by themselves meet criteria for a separate dissociative disorder unless the dissociative phenomenology dominates the clinical picture.

vs. Major depressive disorder with trauma history

Many trauma survivors have MDD as their predominant clinical presentation without meeting full PTSD or C-PTSD criteria. The treatment overlaps substantially but specific trauma-focused therapy may or may not be indicated depending on whether trauma reminders actively trigger symptoms.

First-line treatments

Phase-based treatment (stabilization first)

Cloitre and colleagues' STAIR (Skills Training in Affective and Interpersonal Regulation) plus Narrative Therapy is the most-studied phase-based protocol. Phase 1 (8-10 sessions): emotion regulation skills, interpersonal effectiveness, present-moment grounding, safety planning. Phase 2 (8-10 sessions): trauma narrative work using gradual exposure techniques adapted for C-PTSD pacing. Phase 3 (variable): reintegration, meaning-making, relationship work. The phase-based structure is what distinguishes C-PTSD treatment from acute PTSD treatment.

Trauma-focused CBT with adaptation

CBT-based protocols developed for PTSD (Prolonged Exposure, Cognitive Processing Therapy) can be effective in C-PTSD but typically require adaptation: slower pacing, more attention to stabilization before exposure work, more co-regulation in session, and explicit attention to the relational dynamics that the trauma damaged. Standard 12-session protocols often extend to 20+ sessions in C-PTSD.

EMDR with phase-based adaptation

Eye Movement Desensitization and Reprocessing developed for single-incident trauma can be applied to C-PTSD with the same phase-based modifications: stabilization phase before reprocessing, careful selection of target memories starting with less-charged material, attention to relational rupture and repair within the therapy. EMDR can be particularly effective for specific traumatic memories that loop within the broader C-PTSD picture.

Internal Family Systems (IFS)

IFS (Schwartz) has growing evidence in complex trauma. The "parts" framework — protective parts, exiled parts, vulnerable parts — fits well with the dissociated self-states common in C-PTSD. IFS phase 1 work (Self-leadership, "unburdening" exiled parts) provides stabilization; phase 2 work approaches trauma material through the parts framework rather than direct narrative exposure.

Somatic Experiencing (SE) and sensorimotor psychotherapy

Body-based trauma therapies developed by Levine (SE) and Ogden (sensorimotor) target the somatic and autonomic dysregulation prominent in C-PTSD. Useful for patients with strong somatic surfacing or for whom verbal trauma narrative is initially impossible. Often combined with verbal therapies in phased treatment plans.

SSRI pharmacotherapy

Sertraline and paroxetine have FDA approval for PTSD; effect sizes in C-PTSD are likely similar though less specifically studied. SSRIs do not by themselves treat C-PTSD but reduce hyperarousal, intrusive symptoms, and comorbid depression enough to enable therapy engagement. Continue for at least 12 months after response given high relapse risk.

Group therapy and survivor communities

Trauma-focused group therapy (Seeking Safety, trauma-focused IPT in groups) and peer-survivor communities provide normalization and reduce the relational isolation characteristic of C-PTSD. Groups are typically phase 1 / stabilization-phase work; processing of individual trauma material remains primarily in individual therapy.

When standard treatments fail

For treatment-resistant C-PTSD: extend phase 1 stabilization rather than rushing to processing — many apparent treatment failures are processing attempts before stabilization was adequate. Consider switching therapy modality (CBT → IFS, EMDR → SE, individual → group) rather than abandoning treatment. Add or optimize SSRI pharmacotherapy. Consider rapid-acting options for the depressive symptoms that often accompany treatment-resistant C-PTSD. For severe cases: residential trauma treatment programs, intensive outpatient programs, and specialty trauma centers offer multidisciplinary care that outpatient therapy alone cannot provide. The Cloitre 2025 World Psychiatry review describes the current state of the field and the case for ICD-11 C-PTSD as a clinically useful distinct construct.

Where ketamine fits

Ketamine in complex PTSD specifically has a small but emerging evidence base. The Beaglehole, Glue, and colleagues' 2025 BJPsych Open RCT of ketamine for treatment-resistant PTSD showed measurable benefit, with potential extension to C-PTSD though that trial was not C-PTSD-specific. Mechanistically, ketamine's effect on glutamatergic plasticity and memory reconsolidation has plausible relevance to trauma-memory reprocessing — some integration models pair ketamine sessions with concurrent trauma-focused therapy (EMDR, CPT) to leverage the post-session window for processing work. Critical considerations specific to C-PTSD: (1) Dissociation is already prominent in C-PTSD; ketamine's dissociative phenomenology can amplify pre-existing dissociative patterns in vulnerable patients. Careful screening and preparation matter. (2) Trauma material may surface intensely during or after sessions. Patients need a containing context — established therapy relationship, prepared integration plan, sufficient stabilization in place. (3) The phase-based principle still applies: ketamine in phase 1 / unstable state is more likely to destabilize than help; ketamine after adequate stabilization can be a productive accelerant for phase 2 work.

Where this fits with Tovani

Tovani treats complex PTSD with explicit phase-based framing. Patients with significant C-PTSD presentations are evaluated for stabilization adequacy before treatment begins — established trauma-focused therapy relationship, demonstrated emotion regulation skills, and explicit integration plan. The screening pays particular attention to dissociation history (PCL-5 dissociation subscale, DES-II), suicidality history, and current therapeutic support. Patients in active crisis or without established trauma therapy are typically deferred until phase 1 work has progressed adequately. Tovani encourages and helps connect patients with C-PTSD-experienced therapists (IFS, EMDR, SE, KAP-trained).

Frequently asked

Is complex PTSD a real diagnosis?

In ICD-11 (used by WHO and much of the world): yes, C-PTSD is a distinct diagnosis (code 6B41). In DSM-5-TR (used in the U.S.): no, C-PTSD is not a separate diagnosis — these presentations fall under PTSD with the dissociative subtype specifier or related specifiers. The DSM and ICD systems disagree; the clinical reality of cumulative or relational trauma producing the broader symptom picture is widely recognized regardless of diagnostic system.

How is C-PTSD different from regular PTSD?

ICD-11 C-PTSD requires all three classical PTSD symptom clusters PLUS three additional "disturbances in self-organization" clusters: affective dysregulation (intense emotional reactions, difficulty calming), negative self-concept (persistent beliefs about being worthless or damaged), and disturbances in relationships (difficulty trusting and sustaining close relationships). Single-incident PTSD typically doesn't produce these broader self-organization disturbances at the same level.

Will ketamine help my complex PTSD?

The evidence base in C-PTSD specifically is small but ketamine has emerging evidence in treatment-resistant PTSD that likely extends to many C-PTSD presentations. Critical considerations: phase-based work matters (stabilization first); existing trauma therapy relationship is essentially required for containing surfaced material; dissociation history needs evaluation because ketamine can amplify pre-existing dissociative patterns.

Do I need to do trauma processing during ketamine sessions?

No — and many C-PTSD patients should NOT do intensive trauma processing during ketamine sessions. The session itself is typically an interior experience; trauma work happens in the integration period afterward (and in the broader therapy relationship). For C-PTSD specifically, pacing matters more than processing volume; the post-session neuroplastic window is better used for emotion regulation skills and self-compassion work than for direct trauma narrative.

How long does C-PTSD treatment take?

Substantially longer than single-incident PTSD treatment. Most C-PTSD patients work with their therapist for 18-36 months minimum, often longer. The phase-based structure means phase 1 (stabilization) alone may take 6-12 months; phase 2 (processing) another 6-18 months; phase 3 (integration) ongoing. Ketamine, when used, is typically introduced after adequate stabilization rather than at the beginning of treatment.

References

  1. Cloitre M. 2025, World Psychiatry Review of ICD-11 PTSD and complex PTSD — argues for the clinical utility of the C-PTSD distinction, summarizes the evidence base for phase-based treatment, and addresses ongoing controversies including the DSM-5-TR / ICD-11 divergence. (PMID 39810659)
  2. Sanacora G et al. 2017, JAMA Psychiatry APA consensus statement on ketamine in mood disorders — addresses use in trauma-spectrum disorders including PTSD with extensions to complex trauma presentations. (PMID 28249076)
  3. Murrough JW et al. 2013, American Journal of Psychiatry Ketamine RCT in treatment-resistant depression — foundational rapid-acting antidepressant mechanism with extensions to trauma-spectrum disorders including PTSD and complex PTSD presentations. (PMID 23982301)

Last reviewed by Dr. Ben Soffer, DO on May 27, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.